医学文献 >>
  • 检索发现
  • 增强检索
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
默认
×
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

Plain language summary of isatuximab plus carfilzomib, lenalidomide, and dexamethasone for the treatment of people with high-risk newly diagnosed multiple myeloma.

广告
第一作者: Lisa B,Leypoldt
第一单位: Department of Hematology, Oncology & Bone Marrow Transplantation With Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
作者单位: Department of Hematology, Oncology & Bone Marrow Transplantation With Section of Pneumology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. [1] Division of Biostatistics, German Cancer Research Center (DKFZ) Heidelberg, Heidelberg, Germany. [2] Department of Hematology, Oncology, Immunology & Rheumatology, University Hospital of Tuebingen, Tuebingen, Germany. [3] Department of Hematology, Oncology & Bone Marrow Transplantation, Klinikum Chemnitz, Chemnitz, Germany. [4] Internal Medicine V & National Center for Tumor Diseases, University Hospital Heidelberg, Heidelberg, Germany. [5] Department of Hematology, Oncology & Immunology, University Hospital of Gießen & Marburg, Marburg, Germany. [6] Department of Internal Medicine III, University Medical Center Mainz, Mainz, Germany. [7] Department of Hematology & Stem Cell Transplantation, University Hospital Essen, University Duisburg-Essen, German Cancer Consortium (DKTK partner site Essen), Essen, Germany. [8] Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin & Humboldt-Universität zu Berlin, Departement of Hematology & Oncology, Germany. [9] Department of Hematology, Oncology & Palliative Care, Klinikum Bielefeld Mitte, Bielefeld, Germany. [10] Department of Internal Medicine, Hematology & Oncology, Johanniter Krankenhaus Bonn, Bonn, Germany. [11] Department of Internal Medicine, Hematology, Oncology & Palliative Medicine, Vivantes Klinikum Neukölln, Berlin, Germany. [12] Asklepios Tumorzentrum Hamburg, AK Altona & AK St. Georg, Hamburg, Germany. [13] Department of Internal Medicine I, University Hospital Cologne, Cologne, Germany. [14] Department of Hematology, Oncology & Gastroenterology Kliniken Maria Hilf, Mönchengladbach, Germany. [15] Department of Oncology, Hematology & Stem Cell Transplantation, Klinikum Osnabrück, Osnabrück, Germany. [16] Department of Hematology & Oncology, St. Antonius Hospital Eschweiler, Eschweiler, Germany. [17] Department of Hematology & Oncology, Vivantes Klinikum am Urban, Berlin, Germany. [18] Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany. [19] Institute of Human Genetics, University of Heidelberg, Heidelberg, Germany. [20] Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany. [21] Center for Clinical Trials, University Hospital of Tuebingen, Tuebingen, Germany. [22] Internal Medicine V, GMMG-Studygroup at University Hospital Heidelberg, Germany. [23]
DOI 10.1080/14796694.2024.2402639
PMID 39345094
发布时间 2025-01-04
提交
  • 浏览1
Future oncology (London, England)

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

法律状态公告日 法律状态 法律状态信息

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new医文AI 翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷